Maureen H. Beresini

3.4k total citations
34 papers, 1.2k citations indexed

About

Maureen H. Beresini is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Maureen H. Beresini has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in Maureen H. Beresini's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Cell Adhesion Molecules Research (7 papers) and Immunotherapy and Immune Responses (4 papers). Maureen H. Beresini is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Cell Adhesion Molecules Research (7 papers) and Immunotherapy and Immune Responses (4 papers). Maureen H. Beresini collaborates with scholars based in United States, France and Switzerland. Maureen H. Beresini's co-authors include Kevin Clark, Lois B. Epstein, Michael F. T. Koehler, Sarah Bodary, Hans‐Peter Gerber, Gieri Camenisch, Austin Gurney, Daniel Sherman, Joe Kowalski and N. Ferrara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Maureen H. Beresini

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen H. Beresini United States 22 560 214 200 168 137 34 1.2k
Bo‐Sheng Pan United States 11 1.1k 1.9× 268 1.3× 290 1.4× 139 0.8× 206 1.5× 16 1.6k
Timothy P. Kogan United States 21 543 1.0× 145 0.7× 97 0.5× 51 0.3× 169 1.2× 38 1.2k
D.J. Tyrrell United States 14 662 1.2× 46 0.2× 135 0.7× 165 1.0× 129 0.9× 15 1.2k
Nader Hanna United States 11 724 1.3× 221 1.0× 594 3.0× 364 2.2× 110 0.8× 16 1.6k
Fernando Doñate United States 22 897 1.6× 56 0.3× 508 2.5× 341 2.0× 224 1.6× 56 1.8k
Renta Hutabarat United States 12 1000 1.8× 194 0.9× 74 0.4× 208 1.2× 216 1.6× 22 1.7k
Kwan Y. Hui United States 13 300 0.5× 115 0.5× 61 0.3× 153 0.9× 92 0.7× 23 803
Despina S. Kolonias United States 16 783 1.4× 172 0.8× 576 2.9× 97 0.6× 383 2.8× 23 1.5k
M. Satya Murthy United States 16 273 0.5× 73 0.3× 267 1.3× 83 0.5× 132 1.0× 36 726
Martin Schlesinger Germany 20 586 1.0× 54 0.3× 590 3.0× 287 1.7× 242 1.8× 40 1.4k

Countries citing papers authored by Maureen H. Beresini

Since Specialization
Citations

This map shows the geographic impact of Maureen H. Beresini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen H. Beresini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen H. Beresini more than expected).

Fields of papers citing papers by Maureen H. Beresini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen H. Beresini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen H. Beresini. The network helps show where Maureen H. Beresini may publish in the future.

Co-authorship network of co-authors of Maureen H. Beresini

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen H. Beresini. A scholar is included among the top collaborators of Maureen H. Beresini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen H. Beresini. Maureen H. Beresini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ke Sherry, John G. Quinn, Matthew J. Saabye, et al.. (2022). High-Throughput Kinetic Characterization of Irreversible Covalent Inhibitors of KRASG12C by Intact Protein MS and Targeted MRM. Analytical Chemistry. 94(2). 1230–1239. 25 indexed citations
2.
Ferri, Elena, Adrien Le Thomas, Heidi Ackerly Wallweber, et al.. (2020). Activation of the IRE1 RNase through remodeling of the kinase front pocket by ATP-competitive ligands. Nature Communications. 11(1). 6387–6387. 30 indexed citations
3.
Chernov-Rogan, Tania, Tianbo Li, Gang Lü, et al.. (2018). Mechanism-specific assay design facilitates the discovery of Nav1.7-selective inhibitors. Proceedings of the National Academy of Sciences. 115(4). E792–E801. 25 indexed citations
4.
Jin, Lingyan, Emily Chan, Ehud Segal, et al.. (2017). Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer. Cancer Research. 77(20). 5564–5575. 105 indexed citations
5.
Li, Juan, Blair Wilson, Pamela Chan, et al.. (2017). High throughput screening identifies novel, cell cycle‐arresting small molecule enhancers of transient protein expression. Biotechnology Progress. 33(6). 1579–1588. 8 indexed citations
6.
Koehler, Michael F. T., Philippe Bergeron, Elizabeth M. Blackwood, et al.. (2016). Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells. ACS Medicinal Chemistry Letters. 7(3). 223–228. 65 indexed citations
7.
Bergeron, Philippe, Michael F. T. Koehler, Elizabeth M. Blackwood, et al.. (2016). Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8. ACS Medicinal Chemistry Letters. 7(6). 595–600. 47 indexed citations
8.
Jones, Steven W., Kevin Clark, Amy Gustafson, et al.. (2015). Compound Transfer by Acoustic Droplet Ejection Promotes Quality and Efficiency in Ultra-High-Throughput Screening Campaigns. SLAS TECHNOLOGY. 21(1). 64–75. 22 indexed citations
9.
Liu, Yichin, Maureen H. Beresini, Adam R. Johnson, et al.. (2011). Case Studies of Minimizing Nonspecific Inhibitors in HTS Campaigns That Use Assay-Ready Plates. SLAS DISCOVERY. 17(2). 225–236. 7 indexed citations
10.
Lu, Yanmei, Jean-Michel Vernes, Nancy Chiang, et al.. (2010). Identification of IgG1 variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: Comparison of soluble receptor-based and cell-based binding assays. Journal of Immunological Methods. 365(1-2). 132–141. 25 indexed citations
11.
Olivero, Alan G., Charles Eigenbrot, Richard Goldsmith, et al.. (2005). A Selective, Slow Binding Inhibitor of Factor VIIa Binds to a Nonstandard Active Site Conformation and Attenuates Thrombus Formation in Vivo. Journal of Biological Chemistry. 280(10). 9160–9169. 36 indexed citations
12.
13.
Zobel, Kerry, et al.. (2003). Phosphate ester serum albumin affinity tags greatly improve peptide half-life in vivo. Bioorganic & Medicinal Chemistry Letters. 13(9). 1513–1515. 24 indexed citations
14.
Burdick, Daniel J., Kenneth J. Weese, Mark Stanley, et al.. (2003). N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure–activity relationship. Bioorganic & Medicinal Chemistry Letters. 13(6). 1015–1018. 15 indexed citations
15.
Cai, Liping, Franklin W. Okumu, Jeffrey L. Cleland, et al.. (2002). A slow release formulation of insulin as a treatment for osteoarthritis. Osteoarthritis and Cartilage. 10(9). 692–706. 41 indexed citations
16.
Camenisch, Gieri, M. Teresa Pisabarro, Daniel Sherman, et al.. (2002). ANGPTL3 Stimulates Endothelial Cell Adhesion and Migration via Integrin αvβ3 and Induces Blood Vessel Formation in Vivo. Journal of Biological Chemistry. 277(19). 17281–17290. 205 indexed citations
17.
Skelton, Nicholas J., Kevin Clark, D. Y. JACKSON, et al.. (1998). Transfer of a protein binding epitope to a minimal designed peptide. Biopolymers. 47(4). 265–275. 8 indexed citations
18.
Kumar, Amit, et al.. (1996). α-Subunit of Farnesyltransferase Is Phosphorylatedin Vivo:Effect of Protein Phosphatase-1 on Enzymatic Activity. Biochemical and Biophysical Research Communications. 222(2). 445–452. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026